ArticleJournal of the American Heart Association2014

Acute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation.

Chen Huei Leo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.